Which of the following is an adverse reaction associated with galcanezumab?

Prepare for the Pharmacology IV – Headache Therapeutics Test. Review the therapeutic approaches, tackle multiple-choice questions with explanations, and boost your test-taking confidence. Ace your exam with precision!

Multiple Choice

Which of the following is an adverse reaction associated with galcanezumab?

Galcanezumab is a subcutaneously injected monoclonal antibody against CGRP used to prevent migraine. Because it is given by injection, the most common adverse reaction is a local reaction at the injection site. These injection-site reactions manifest as pain, redness, swelling, or induration and are typical with biologic therapies administered by SC injection. Nausea, dizziness, and fatigue can occur with various drugs, but they are not the characteristic adverse effects associated with galcanezumab. The local injection-site reaction is the best-supported adverse event for this medication because it directly relates to the route and nature of administration, whereas the others are less specific to this agent and occur less consistently. These local reactions are usually mild and transient.

Galcanezumab is a subcutaneously injected monoclonal antibody against CGRP used to prevent migraine. Because it is given by injection, the most common adverse reaction is a local reaction at the injection site. These injection-site reactions manifest as pain, redness, swelling, or induration and are typical with biologic therapies administered by SC injection.

Nausea, dizziness, and fatigue can occur with various drugs, but they are not the characteristic adverse effects associated with galcanezumab. The local injection-site reaction is the best-supported adverse event for this medication because it directly relates to the route and nature of administration, whereas the others are less specific to this agent and occur less consistently. These local reactions are usually mild and transient.

More practice questions